A report from the National Institute of Allergy and Infectious Diseases covers new research that suggests that intermittent anti-retroviral therapy is just as effective as continuous anti-retroviral therapy in curbing HIV. Which means that we can spread existing resources further in the battle against HIV. Not to mention the lower toxicity of an intermittent treatment regimen.
Details can be found here with further links to the publication in PLoS ONE.
